FOXO1 and muscular disease: Taken together, SIRT1-mediated deacetylation of Foxo1 may represent an important therapeutic mechanism of resveratrol in muscle disorders; although whether these findings would be extrapolated in compression-induced injury in the skeletal muscle warrant further research.